LSI Segment Divestment

grun NORTH 8Y15 sev Full-Year 2020 LPBN Performance Overview Performance driven by YoY sales growth and margin increase Strong full-year performance, driven by Biologics business All businesses managed COVID-19 impacts and maintained business continuity Businesses have worked to expand their service offerings and manufacturing capacity Sales growth momentum expected to continue into 2021 New divisional structure implemented from 1 January 2021. New financial reporting structure will commence from H1 2021 20 20

View entire presentation